Perialar intertrigo in children and adolescents: A multicenter prospective study of 41 cases.


Journal

Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 21 10 2021
accepted: 01 05 2022
pubmed: 15 6 2022
medline: 12 10 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

We observed isolated cases of perialar intertrigo in children and teenagers that did not appear to correspond to any known clinical entity. The objective of this study was to describe the clinical features of this dermatosis and the clinical characteristics of the patients. We conducted a prospective, multicenter cohort study in France from August 2017 to November 2019. All the patients under 18 years of age with chronic perinasal intertrigo were included. A standardized questionnaire detailing the clinical characteristics of the patients and the description of the intertrigo. If possible, a Wood's lamp examination of the intertrigo was done. Forty-one patients were included (25 boys and 16 girls, average age: 12.1 years). Intertrigo was bilateral in 38 patients (93%). The majority of patients had no symptoms (54%). Pruritus was present in 39% of cases. Orange red follicular fluorescence was present in the perialar region on Wood's light examination in 78% of cases with active fluorescence. The presumptive diagnoses suggested by the investigators were acne (24.4%), seborrheic dermatitis (19.5%), rosacea (9.8%), psoriasis (9.8%) and perioral dermatitis (7.3%). No diagnosis was proposed in 22% of the cases. We describe a previously undescribed clinical sign which is characterized by a chronic bilateral erythematous intertrigo located in the perialar region. It can be isolated or associated with various facial dermatoses.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
We observed isolated cases of perialar intertrigo in children and teenagers that did not appear to correspond to any known clinical entity. The objective of this study was to describe the clinical features of this dermatosis and the clinical characteristics of the patients.
METHODS METHODS
We conducted a prospective, multicenter cohort study in France from August 2017 to November 2019. All the patients under 18 years of age with chronic perinasal intertrigo were included. A standardized questionnaire detailing the clinical characteristics of the patients and the description of the intertrigo. If possible, a Wood's lamp examination of the intertrigo was done.
RESULTS RESULTS
Forty-one patients were included (25 boys and 16 girls, average age: 12.1 years). Intertrigo was bilateral in 38 patients (93%). The majority of patients had no symptoms (54%). Pruritus was present in 39% of cases. Orange red follicular fluorescence was present in the perialar region on Wood's light examination in 78% of cases with active fluorescence. The presumptive diagnoses suggested by the investigators were acne (24.4%), seborrheic dermatitis (19.5%), rosacea (9.8%), psoriasis (9.8%) and perioral dermatitis (7.3%). No diagnosis was proposed in 22% of the cases.
CONCLUSIONS CONCLUSIONS
We describe a previously undescribed clinical sign which is characterized by a chronic bilateral erythematous intertrigo located in the perialar region. It can be isolated or associated with various facial dermatoses.

Identifiants

pubmed: 35699273
doi: 10.1111/pde.15036
pmc: PMC9796429
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

702-707

Subventions

Organisme : Société Française de Dermatologie

Informations de copyright

© 2022 The Authors. Pediatric Dermatology published by Wiley Periodicals LLC.

Références

Science. 2009 May 29;324(5931):1190-2
pubmed: 19478181
J Clin Med. 2019 Jul 07;8(7):
pubmed: 31284694
Br J Dermatol. 1980 Apr;102(4):437-41
pubmed: 7387886
Allergy. 2001 Oct;56(10):944-8
pubmed: 11576072
J Invest Dermatol. 1967 Oct;49(4):368-70
pubmed: 4228644
Pediatr Dermatol. 2022 Sep;39(5):702-707
pubmed: 35699273
Ann Dermatol Venereol. 2002 Jan;129(1 Pt 1):68
pubmed: 11937936
Arch Dermatol. 2003 Mar;139(3):318-22
pubmed: 12622623
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):298-306
pubmed: 28707712
J Dtsch Dermatol Ges. 2005 Apr;3(4):252-5
pubmed: 16370472
J Bacteriol. 1978 Feb;133(2):811-5
pubmed: 637914
Dermatol Ther. 2020 Nov;33(6):e13972
pubmed: 32621774
J Zhejiang Univ Sci B. 2011 Dec;12(12):998-1007
pubmed: 22135149
Pediatr Dermatol. 1983 Oct;1(2):157-64
pubmed: 6239147
Dermatol Online J. 2011 Jan 15;17(1):1
pubmed: 21272492

Auteurs

Adrien Sanchez (A)

Department of Dermatology-Venereology, Hôpital Archet 2, CHU de Nice, Nice, France.

Emmanuel Mahe (E)

Department of Dermatology-Venereology, Centre Hospitalier d'Argenteuil, Argenteuil, France.

Juliette Miquel (J)

Pediatric Dermatology Unit, Hôpital de Saint Pierre, CHU de la Réunion, Saint Pierre, France.

Claire Abasq (C)

Department of Dermatology-Venereology, Hôpital Morvan, CHU de Brest, Brest, France.

Alice Phan (A)

Pediatric Dermatology Unit, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Bron, France.

Juliette Mazereeuw-Hautier (J)

Department of Dermatology-Venereology, Hôpital Larre, CHU de Toulouse, Toulouse, France.

Juliette Lemille (J)

General Medicine, Hôpital Saint-Jacques, CHU de Nantes, Nantes, France.

Annabel Maruani (A)

Department of Dermatology, Unit of Paediatric Dermatology, University of Tours, CHU de Tours, Tours, France.

Bertille Bonniaud (B)

Department of Dermatology-Venereology, CHU de Dijon, Dijon, France.

Patrice Plantin (P)

Department of Dermatology-Venereology, Centre Hospitalier de Quimper, Quimper, France.

Stéphanie Mallet (S)

Department of Dermatology-Venereology, Hôpital de la Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.

Hélène Martin (H)

Department of Dermatology-Venereology, Hôpital Archet 2, CHU de Nice, Nice, France.

Thomas Hubiche (T)

Department of Dermatology-Venereology, Hôpital Archet 2, CHU de Nice, Nice, France.

Christine Chiaverini (C)

Department of Dermatology-Venereology, Hôpital Archet 2, CHU de Nice, Nice, France.

Jean-Philippe Lacour (JP)

Department of Dermatology-Venereology, Hôpital Archet 2, CHU de Nice, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH